Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MBBS, MRCP (London), MRCP (UK), FCPS (Pak)
Diabetologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.C.P.S
Gastroenterologist
M.B.B.S., M.R.C.P (UK), F.R.C.P (UK), CCST GASTROENTEROLOGY/HEPATOLOGY/GENERAL MEDICINE
Gastroenterologist
M.B.B.S., M.R.C.P (UK), F.R.C.P (UK), CCST GASTROENTEROLOGY/HEPATOLOGY/GENERAL MEDICINE
Consultant Physician
M.B.B.S., F.C.P.S., Diploma in Diabetes
Internal Medicine Specialist
M.B.B.S, M.D (USA), M.C.P.S, M.R.C.G.P
Internal Medicine Specialist
M.B.B.S, M.C.P.S, F.C.P.S.
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures